logo
Share SHARE
FONT-SIZE Plus   Neg

Medtronic Posts Results From Trial Evaluating Its CoreValve System

Medtronic, Inc. (MDT) announced results from its largest international, prospective, single-arm clinical trial evaluating the Medtronic CoreValve System in patients with severe aortic stenosis who are at high-risk for surgical aortic valve replacement, or SAVR.

The data showed that patients in a real-world setting experienced high procedural success combined with positive clinical outcomes. At present, the CoreValve System is limited to investigational use in the United States.

Called the Medtronic CoreValve ADVANCE Study, survival rates were high at both 30 days and 6 months, rates that are consistent with previously reported data from national registries in Europe. The procedural success rate was 97.8 percent, and overall complication rates were low with stroke rates of 2.9 percent and MACCE (Major Adverse Cardiac & Cerebrovascular Events) rates of 8.3 percent at 30 days. Also, patients in the study experienced significant improvement in valve function.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Theme park chain Six Flags Entertainment Corp. (SIX) announced that it is in "discussions" with the Kingdom of Saudi Arabia to open multiple amusement parks in the conservative Muslim kingdom. Texas-based Six Flags Entertainment says it "has initiated discussions with the government of Saudi Arabia... Uber has developed new software that will track and inform drivers of the ride-hailing app about things like sudden acceleration, harsh braking or whether they are holding their phones while driving. The software is part of an updated version of Uber's app for drivers. One third of its PlayStation Plus users pay for games, Sony revealed on Wednesday.
comments powered by Disqus
Follow RTT